Avadel Pharmaceuticals (AVDL) EBITDA (2015 - 2025)
Avadel Pharmaceuticals (AVDL) EBITDA from Mar 31, 2015 to Sep 30, 2025. The TTM Avadel Pharmaceuticals (AVDL) EBITDA is $6.25M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Avadel Pharmaceuticals (AVDL) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 5 Years TTM | -13.99% |
| All Time TTM | -23.52% |
Annual EBITDA change of Avadel Pharmaceuticals (AVDL)
| Year | EBITDA | Change |
|---|---|---|
| 2025 | $9.14M | -123.01% |
| 2024 | -$40M | -70.81% |
| 2023 | -$136M | +40.19% |
| 2022 | -$97M | +14.56% |
| 2021 | -$85M | -1228.23% |
| 2020 | $7.51M | -134.72% |
| 2019 | -$22M | -77.82% |
| 2018 | -$98M | -203.29% |
| 2017 | $94M | +891.49% |
| 2016 | $9.52M | -88.65% |
| 2015 | $84M | -205.23% |
| 2014 | -$80M | +69.73% |
| 2013 | -$47M | +597.92% |
| 2012 | -$6.73M | +7.85% |
| 2011 | -$6.24M | +21.40% |
| 2010 | -$5.14M | -11.99% |
| 2009 | -$5.84M | N/A |
Comparison Avadel Pharmaceuticals (AVDL) five years EBITDA CAGR with competitors
Avadel Pharmaceuticals (AVDL) five years EBITDA CAGR is -13.98%.